SANTA ROSA, Calif.--(BUSINESS WIRE)--Exchange Bank (OTC: EXSR) today announced results for the first quarter of 2021, reporting net income after taxes of $8.49 million,...
CHICAGO, May 5, 2021 /PRNewswire/ -- RockItCoin, the most trusted name in Bitcoin ATM™, today launched a Spanish-language website, recognizing the importance of access to the burgeoning cryptocurrency market by Spanish-speaking consumers in the United States. The company has become the first to do so, once again leading the industry in supporting greater inclusion and access investing in cryptocurrency for as many people as possible. RockItCoin's multi-language ATMs allow easy, walk-up access and fast conversion of cash into cryptocurrencies. The RockItCoin website also supports online transactions in the following cryptocurrencies: Bitcoin Cash (BCH), Bitcoin (BTC), Ethereum (ETH), and Litecoin (LTC). In addition, for anyone wanting to buy/sell over $10,000, RockItCoin offers a highly personalized OTC service. "Due to language and other constraints, many members of the Hispanic community have been largely shut out from the rising Bitcoin and cryptocurrency markets," said Michael Dalesandro, Founder and CEO of RockItCoin. "RockItCoin's new Spanish-language website and multi-language CryptoATMs are the safest and easiest choice for anyone seeking to turn cash into Bitcoin, Bitcoin Cash, Ethereum, and Litecoin. By making cryptocurrency information accessible to Spanish-speaking consumers, RockItCoin is helping families and Hispanic communities with greater access to financial opportunities and a way to grow their financial assets using cryptocurrency. Spanish-speaking consumers can now find and access a RockItCoin Crypto ATM close to where they live and work with personal customer support 7 days a week." For interest in hosting a crypto ATM, please visit us at https://rockitcoin.com/host. For locations and interest in using one of RockItCoin's crypto ATMs, please visit https://rockitcoin.com/locations About RockItCoin Founded in 2015 by Michael Dalesandro, RockItCoin is a crypto blockchain company based in Chicago, IL. RockItCoin's network of over 1,000 multi-language ATMs across the US provides consumers with an easy, safe, and fast way to buy, sell, and trade Bitcoin. Consumers can also access and manage a wide variety of other cryptocurrencies through the company's Wallet app. In addition, RockItCoin distributes, operates, places, and sells 2-way Bitcoin kiosks to support small businesses gain additional revenue from crypto. For more information, visit: https://rockitcoin.com, En Español: https://rockitcoin.com/es/ SOURCE RockItCoin Related Links https://rockitcoin.com/
The Children's Heart Foundation celebrates 25 years of funding the most promising CHD research! Tweet this "If it were not for our fabulous volunteers and donors, CHF would not exist, period!" says Betsy Peterson, the organization's founder. "I'm so grateful to each and every one of you who has ensured that much needed research for congenital heart defects gets funded." The 25th Anniversary campaign will showcase the role research has played, highlighting breakthrough science and the researchers who led it. There will be opportunities to pay tribute to heart warriors and angels, as well as ways to become a community champion or partner. As much as there is to celebrate, the CHF says that this 25th Anniversary is also a call to action. Each year, research goes unfunded due to the disproportionate lack of funding CHD receives given its prevalence. "Now as we look forward to the next 25 years, our volunteers and donors will play an even bigger role in helping The Children's Heart Foundation meet the demand for funding future CHD research," Peterson stated.CEO Gail Roddie-Hamlin stated, "Our current efforts have been great, but we cannot be satisfied. We must meet the challenges of the next 25 years through continued fundraising, advocacy, and community expansion to fund the best science and research endeavors for all those affected by CHD."Founder Betsy Peterson summed up the organization's goals by stating, "As the mother of a child born with complex congenital heart defects, I know that if it had not been for research, our son Sam would not have lived more than a day. If you think about it, we all stand on the shoulders of those that have gone on before us."Visit The Children's Heart Foundation's website to learn more about the organization's mission at www.childrensheartfoundation.org.SOURCE The Children's Heart Foundation Related Links http://www.childrensheartfoundation.org
On the 29th of July 2020, the CEOs of four of the biggest tech companies in the world were called to testify before the...
EDMONTON, AB, May 6, 2021 /PRNewswire/ - Medo, an artificial intelligence technology start-up company headquartered in Singapore and Canada, is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration for the world's first tool using Artificial Intelligence to drastically simplify the Thyroid ultrasound scanning workflow. The company previously announced the release of an AI assistant for helping diagnose hip dysplasia and is now expanding their technology into other use cases. Over 1.5 million thyroid ultrasound exams are done each year in the USA alone. This high volume is due to the fact that lumps, or "nodules" on the thyroid gland are common and although usually benign, can be cancerous. Each ultrasound exam is non-invasive and safe, but incredibly time consuming and potentially error-prone, involving a tedious review of hundreds of images to locate and measure thyroid nodules individually. This process becomes even more difficult and subjective when the gland has multiple nodules. Using artificial intelligence, Medo has revolutionized the process of performing thyroid studies and turned it into a seamless, fast, and objective workflow. With Medo-Thyroid, the user simply obtains quick video 'sweeps' of each side of the thyroid gland. Medo-Thyroid then seamlessly uses AI to automatically review this data and a) select the optimal images for analysis, b) calculate standard lobe and isthmus measurements, and c) assist to locate, measure and characterize any nodules present using the well-known TI-RADS system. With this information and a single click, Medo-Thyroid creates an individualized interactive report. Dr. Jacob Jaremko, a radiologist and co-founder of Medo, explains that "Medo-Thyroid makes thyroid ultrasound a less frustrating test, by presenting thyroid measurements and nodule characteristics in a convenient format. It's especially helpful to radiologists when following up multiple nodules." Medo-Thyroid contains several key technological breakthroughs, including a cross-referencing ability previously only possible on multi-plane CT and MRI. This feature is designed to assist the user with viewing individual nodules across all planes of interest such as transverse and sagittal. Dr. Dornoosh Zonoobi, co-founder and CEO of Medo, notes that: "With this product, Medo provides both clinical and financial value to the stakeholders. We are particularly pleased with the feedback we have received from many of the independent clinicians who have used our product stating that this will greatly benefit them in their everyday workflow." About MEDO.ai MEDO is an artificial intelligence technology start-up company dual headquartered in Edmonton, Canada and Singapore. MEDO builds cutting edge artificial intelligence that pairs with ultrasound devices to facilitate novice users' ability to detect common and critical conditions, even in remote and rural areas. MEDO believes that such technology will transform ultrasound for the 21st century. For more information, visit https://medo.ai/. SOURCE Medo Related Links www.medo.ai
USD - United States Dollar